Header

UZH-Logo

Maintenance Infos

Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial


Schreglmann, S R; Büchele, F; Sommerauer, M; Epprecht, L; Kägi, G; Hägele-Link, S; Götze, O; Zimmerli, L; Waldvogel, D; Baumann, C R (2017). Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial. European Journal of Neurology, 24(4):545-551.

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
2 citations in Scopus®
4 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

27 downloads since deposited on 09 Nov 2017
27 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:April 2017
Deposited On:09 Nov 2017 16:57
Last Modified:01 May 2018 00:06
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1351-5101
OA Status:Green
Publisher DOI:https://doi.org/10.1111/ene.13260
PubMed ID:28224720

Download

Download PDF  'Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 233kB
View at publisher